Stay updated on COR388 for AD: Phase 2/3 Clinical Trial

Sign up to get notified when there's something new on the COR388 for AD: Phase 2/3 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the COR388 for AD: Phase 2/3 Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Two screenshots of the Study Details page show no additions or deletions to core content; the content, sections, and navigation appear unchanged aside from minor visual formatting. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T21:22:15.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    - Added a government funding notice with operational details and links; - Updated version to v3.2.0; - Removed reference to v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T05:50:16.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Updated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the older version tag v3.0.2, suggesting a reorganization of content around a new version.
    Difference
    0.3%
    Check dated 2025-09-29T03:11:52.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; Back to Top link removed.
    Difference
    0.2%
    Check dated 2025-09-14T19:58:27.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T17:04:57.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of new facility names and locations, as well as new topics related to drug safety and Alzheimer's care. Notably, previous entries have been removed, indicating a shift in focus or content structure.
    Difference
    3%
    Check dated 2025-08-31T12:17:55.000Z thumbnail image

Stay in the know with updates to COR388 for AD: Phase 2/3 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the COR388 for AD: Phase 2/3 Clinical Trial page.